Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-14-002901
Filing Date
2014-09-08
Accepted
2014-09-08 20:11:01
Documents
1
Period of Report
2014-09-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4.html 4  
1 OWNERSHIP DOCUMENT form4.xml 4 3602
  Complete submission text file 0001493152-14-002901.txt   5183
Mailing Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121
Business Address
AUSTIN STEPHEN G (Reporting) CIK: 0001219121 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 141092120

Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations